Construction of a Database for TTP

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-20

Study Completion Date

2028-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Oct 20, 2022, to Oct 20, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical related data of thrombotic thrombocytopenic purpura.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers

NCT00005570

Purpura, Thrombocytopenic, Idiopathic Immune Thrombocytopenic Purpura

COMPLETED

Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)

NCT06107582

Primary Immune Thrombocytopenia

RECRUITING

The International ITP Registry

NCT01970189

Thrombocytopenia

UNKNOWN

A 6-month Follow-up Study of Patients With Severe Fever With Thrombocytopenia Syndrome

NCT06011902

Severe Fever With Thrombocytopenia Syndrome

UNKNOWN

.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)

NCT05389007

Thrombotic Thrombocytopenic Purpura

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

TTP - Thrombotic Thrombocytopenic Purpura

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TTP

TTP patients

collection data

Intervention Type OTHER

collection data

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

collection data

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Subjects diagnosed with severe ADAMTS13 deficiency, defined as ADAMTS13 activity \<10%, documented in the patient's medical history or at screening.